95 related articles for article (PubMed ID: 27181260)
1. Treatment of cerebral radiation necrosis with nerve growth factor: A prospective, randomized, controlled phase II study.
Wang XS; Ying HM; He XY; Zhou ZR; Wu YR; Hu CS
Radiother Oncol; 2016 Jul; 120(1):69-75. PubMed ID: 27181260
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer.
Liu P; Niu X; Ou D; Qiu J; Lou P; Xue L; Zhou X; Xu T; Wang X
Front Oncol; 2020; 10():450. PubMed ID: 32391255
[No Abstract] [Full Text] [Related]
3. A study of radiation-induced cerebral vascular injury in nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
Ye J; Rong X; Xiang Y; Xing Y; Tang Y
PLoS One; 2012; 7(8):e42890. PubMed ID: 22912759
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
Lam TC; Wong FC; Leung TW; Ng SH; Tung SY
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e57-65. PubMed ID: 21300460
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis.
Chan AS; Cheung MC; Law SC; Chan JH
Cancer; 2004 Jan; 100(2):398-404. PubMed ID: 14716777
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of radiation-induced temporal lobe necrosis with mouse nerve growth factor.
Wang X; Ying H; Zhou Z; Hu C; Eisbruch A
J Clin Oncol; 2011 Mar; 29(7):e166-8. PubMed ID: 21149661
[No Abstract] [Full Text] [Related]
7. The use of nerve growth factor in surgical wound healing of the cornea.
Cellini M; Bendo E; Bravetti GO; Campos EC
Ophthalmic Res; 2006; 38(4):177-81. PubMed ID: 16679804
[TBL] [Abstract][Full Text] [Related]
8. [Effect of nerve growth factor on the promotion of sensory recovery of large skin graft in patients].
Wu ZH; Huang J; Gao WH; Wang AL; Jia Q; Chen B; Xu S; Gu YH
Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):440-3. PubMed ID: 18457257
[TBL] [Abstract][Full Text] [Related]
9. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans.
Andersen H; Arendt-Nielsen L; Svensson P; Danneskiold-Samsøe B; Graven-Nielsen T
Exp Brain Res; 2008 Nov; 191(3):371-82. PubMed ID: 18813917
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy.
McDonald MW; Linton OR; Calley CS
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):261-7. PubMed ID: 25636754
[TBL] [Abstract][Full Text] [Related]
11. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice.
Miyagi M; Ishikawa T; Kamoda H; Suzuki M; Inoue G; Sakuma Y; Oikawa Y; Orita S; Uchida K; Takahashi K; Takaso M; Ohtori S
BMC Musculoskelet Disord; 2017 Nov; 18(1):428. PubMed ID: 29100502
[TBL] [Abstract][Full Text] [Related]
13. Siatic nerve regeneration in rats stimulated by fibrin glue containing nerve growth factor: an experimental study.
Gao C; Ma S; Ji Y; Wang JE; Li J
Injury; 2008 Dec; 39(12):1414-20. PubMed ID: 18715558
[TBL] [Abstract][Full Text] [Related]
14. Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management.
Zhou X; Liu P; Wang X
Front Oncol; 2020; 10():593487. PubMed ID: 33552967
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of mouse nerve growth factor in the treatment of sudden deafness].
Xu T; Xiao D; Wu S; Yuan Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 28(10):735-7. PubMed ID: 25129979
[TBL] [Abstract][Full Text] [Related]
16. [Neuroprotection of nerve growth factor in experiment retinal detachment].
Sun XD; Zhang X; Xu X; Yu Z; Chen RJ
Zhonghua Yan Ke Za Zhi; 2003 May; 39(5):303-7. PubMed ID: 12892609
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on gradient of nerve growth factor immobilized conduits promoting peripheral nerve regeneration in rats].
Lin Q; Cai Y; Li H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Feb; 28(2):167-72. PubMed ID: 24796187
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.
Tan S; Wang RH; Niu HX; Shi CH; Mao CY; Zhang R; Song B; Sun SL; Liu XJ; Hou HM; Liu YT; Gao Y; Fang H; Kong XD; Xu YM
Chin Med J (Engl); 2015 Feb; 128(3):291-4. PubMed ID: 25635421
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study on the protection effect of nerve growth factor and edaravone pretreatment against cerebral ischemia/reperfusion injury].
Fu JQ; Wang DF; Liu H
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):226-9. PubMed ID: 20398467
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor delivery by ultrasound-mediated nanobubble destruction as a treatment for acute spinal cord injury in rats.
Song Z; Wang Z; Shen J; Xu S; Hu Z
Int J Nanomedicine; 2017; 12():1717-1729. PubMed ID: 28280337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
